The statements in this article have not been evaluated by any regulatory authority to diagnose, treat, cure, or prevent any disease
Laboratory monitoring may include baseline and periodic assessment of lipid panel, hemoglobin A1c (if diabetic or prediabetic), liver function tests, and renal function, particularly in patients with pre-existing conditions
Direction of Future Research A multicenter randomized clinical trial is current in progress in Spain primary health-care setting called Project OB12 ( Conclusion Oral vitamin B12 replacement at 1000 g daily is an adequate alternative to IM B12 injections
Regular lipid profile monitoring remains essential, with non-HDL cholesterol the preferred UK measurement for treatment response
GLP-1 analogs and DPP-4 inhibitors in type 2 diabetes therapy: review of head-to-head clinical trials
Why Choose LA Health Solutions for Your Medical Weight Loss Journey